Meredith S Campbell1, Lisa A Bastarache2, Sara L Van Driest1, Margaret A Adgent3, Jeffery A Goldstein4, Joern-Hendrik Weitkamp1, Meaghan A Ransom1, Rolanda L Lister5, Elaine L Shelton1, Jennifer M S Sucre6,7. 1. Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN, USA. 2. Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN, USA. 3. Department of Health Policy, Vanderbilt University Medical Center, Nashville, TN, USA. 4. Department of Pathology, Northwestern University, Chicago, IL, USA. 5. Department of Obstetrics and Gynecology, Vanderbilt University Medical Center, Nashville, TN, USA. 6. Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN, USA. jennifer.sucre@vumc.org. 7. Department of Cell and Developmental Biology, Vanderbilt University Medical Center, Nashville, TN, USA. jennifer.sucre@vumc.org.
Abstract
BACKGROUND: The pathogenesis of bronchopulmonary dysplasia (BPD) is multifactorial, and there are limited data about prenatal exposures and risk of BPD. STUDY DESIGN: Our study performed parallel analyses using a logistic regression model in a cohort of 4527 infants with data from a curated registry and using a phenome wide association study (PheWAS) based on ICD9/10-based phecodes. We examined 20 prenatal exposures from a neonatal intensive care unit (NICU) curated registry database related to pregnancy and maternal health as well as 94 maternal diagnosis phecodes with a PheWAS analysis. RESULT: In both the curated registry and PheWAS analyses, polyhydramnios was associated with an increased risk of BPD (OR 5.70, 95% CI 2.78-11.44, p = 1.37 × 10-6). CONCLUSION: Our data suggest that polyhydramnios may be a clinical indicator of premature infants at increased risk for bronchopulmonary dysplasia. Combining curated registry data with PheWAS analysis creates a valuable tool to generate hypotheses. IMPACT: Polyhydramnios was significantly associated with bronchopulmonary dysplasia in both a curated registry and by ICD coding analysis with a phenome wide association study (PheWAS). Preterm polyhydramnios may be a clinical indicator of infants at increased risk for developing bronchopulmonary dysplasia after preterm birth. Combining curated registry with PheWAS analysis creates a valuable tool to generate hypotheses about perinatal risk factors and morbidities associated with preterm birth.
BACKGROUND: The pathogenesis of bronchopulmonary dysplasia (BPD) is multifactorial, and there are limited data about prenatal exposures and risk of BPD. STUDY DESIGN: Our study performed parallel analyses using a logistic regression model in a cohort of 4527 infants with data from a curated registry and using a phenome wide association study (PheWAS) based on ICD9/10-based phecodes. We examined 20 prenatal exposures from a neonatal intensive care unit (NICU) curated registry database related to pregnancy and maternal health as well as 94 maternal diagnosis phecodes with a PheWAS analysis. RESULT: In both the curated registry and PheWAS analyses, polyhydramnios was associated with an increased risk of BPD (OR 5.70, 95% CI 2.78-11.44, p = 1.37 × 10-6). CONCLUSION: Our data suggest that polyhydramnios may be a clinical indicator of premature infants at increased risk for bronchopulmonary dysplasia. Combining curated registry data with PheWAS analysis creates a valuable tool to generate hypotheses. IMPACT: Polyhydramnios was significantly associated with bronchopulmonary dysplasia in both a curated registry and by ICD coding analysis with a phenome wide association study (PheWAS). Preterm polyhydramnios may be a clinical indicator of infants at increased risk for developing bronchopulmonary dysplasia after preterm birth. Combining curated registry with PheWAS analysis creates a valuable tool to generate hypotheses about perinatal risk factors and morbidities associated with preterm birth.
Authors: John T Benjamin; Billy J Carver; Erin J Plosa; Yasutoshi Yamamoto; J Davin Miller; Jin-Hua Liu; Riet van der Meer; Timothy S Blackwell; Lawrence S Prince Journal: J Immunol Date: 2010-09-22 Impact factor: 5.422
Authors: Steven H Abman; Joseph M Collaco; Edward G Shepherd; Martin Keszler; Milenka Cuevas-Guaman; Stephen E Welty; William E Truog; Sharon A McGrath-Morrow; Paul E Moore; Lawrence M Rhein; Haresh Kirpalani; Huayan Zhang; Linda L Gratny; Susan K Lynch; Jennifer Curtiss; Barbara S Stonestreet; Robin L McKinney; Kevin C Dysart; Jason Gien; Christopher D Baker; Pamela K Donohue; Eric Austin; Candice Fike; Leif D Nelin Journal: J Pediatr Date: 2016-11-28 Impact factor: 4.406
Authors: Martina Persson; Prakesh S Shah; Franca Rusconi; Brian Reichman; Neena Modi; Satoshi Kusuda; Liisa Lehtonen; Stellan Håkansson; Junmin Yang; Tetsuya Isayama; Marc Beltempo; Shoo Lee; Mikael Norman Journal: JAMA Pediatr Date: 2018-09-01 Impact factor: 16.193
Authors: Joshua C Denny; Lisa Bastarache; Marylyn D Ritchie; Robert J Carroll; Raquel Zink; Jonathan D Mosley; Julie R Field; Jill M Pulley; Andrea H Ramirez; Erica Bowton; Melissa A Basford; David S Carrell; Peggy L Peissig; Abel N Kho; Jennifer A Pacheco; Luke V Rasmussen; David R Crosslin; Paul K Crane; Jyotishman Pathak; Suzette J Bielinski; Sarah A Pendergrass; Hua Xu; Lucia A Hindorff; Rongling Li; Teri A Manolio; Christopher G Chute; Rex L Chisholm; Eric B Larson; Gail P Jarvik; Murray H Brilliant; Catherine A McCarty; Iftikhar J Kullo; Jonathan L Haines; Dana C Crawford; Daniel R Masys; Dan M Roden Journal: Nat Biotechnol Date: 2013-12 Impact factor: 54.908
Authors: Wei-Qi Wei; Lisa A Bastarache; Robert J Carroll; Joy E Marlo; Travis J Osterman; Eric R Gamazon; Nancy J Cox; Dan M Roden; Joshua C Denny Journal: PLoS One Date: 2017-07-07 Impact factor: 3.240